Smruthi Organics Limited (590046) – Financial and Strategic SWOT Analysis Review – new company profile report – Transworld News

It operates in the bulk drugs and drug intermediates segment. Its products include diloxanide furcate, norfloxacin HS code 2933599090, zidovudine, ciprofloxacin, pefloxacin, metformin hcl, amlodipine, chlorhexidine base, carbidopa, enrofloxacin and phthaloyl amlodipine.